 Jennifer Stevens Lapsley
Concepts (384)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 71 | 2022 | 246 | 23.230 |
Why?
| | Osteoarthritis, Knee | 38 | 2022 | 213 | 12.400 |
Why?
| | Recovery of Function | 40 | 2022 | 577 | 8.540 |
Why?
| | Muscle Strength | 35 | 2022 | 275 | 7.330 |
Why?
| | Quadriceps Muscle | 26 | 2022 | 100 | 6.710 |
Why?
| | Physical Therapy Modalities | 18 | 2020 | 269 | 6.460 |
Why?
| | Knee Joint | 27 | 2022 | 325 | 5.600 |
Why?
| | Activities of Daily Living | 16 | 2022 | 352 | 4.740 |
Why?
| | Arthroplasty, Replacement, Hip | 10 | 2022 | 109 | 3.920 |
Why?
| | Home Care Services | 9 | 2021 | 226 | 3.890 |
Why?
| | Skilled Nursing Facilities | 5 | 2021 | 119 | 3.240 |
Why?
| | Exercise Therapy | 14 | 2020 | 351 | 3.100 |
Why?
| | Aged | 99 | 2022 | 19251 | 3.070 |
Why?
| | Muscle, Skeletal | 33 | 2022 | 1447 | 2.910 |
Why?
| | Range of Motion, Articular | 22 | 2022 | 354 | 2.770 |
Why?
| | Lower Extremity | 10 | 2019 | 337 | 2.510 |
Why?
| | Hospitalization | 14 | 2022 | 1765 | 2.350 |
Why?
| | Mobility Limitation | 6 | 2020 | 60 | 2.270 |
Why?
| | Resistance Training | 8 | 2022 | 116 | 2.190 |
Why?
| | Disability Evaluation | 11 | 2021 | 271 | 2.170 |
Why?
| | Patient Discharge | 11 | 2022 | 770 | 2.120 |
Why?
| | Subacute Care | 6 | 2021 | 70 | 2.050 |
Why?
| | Osteoarthritis, Hip | 5 | 2021 | 40 | 1.970 |
Why?
| | Exercise Test | 12 | 2019 | 539 | 1.930 |
Why?
| | Patient Readmission | 6 | 2021 | 609 | 1.900 |
Why?
| | Middle Aged | 76 | 2022 | 26999 | 1.820 |
Why?
| | Male | 103 | 2022 | 55949 | 1.750 |
Why?
| | Walking | 15 | 2020 | 425 | 1.710 |
Why?
| | Female | 107 | 2022 | 59913 | 1.700 |
Why?
| | Muscle Weakness | 9 | 2019 | 80 | 1.690 |
Why?
| | Humans | 149 | 2022 | 115587 | 1.680 |
Why?
| | Gait | 9 | 2020 | 249 | 1.650 |
Why?
| | Medicare | 9 | 2022 | 666 | 1.640 |
Why?
| | Aged, 80 and over | 33 | 2022 | 6417 | 1.630 |
Why?
| | Isometric Contraction | 17 | 2019 | 152 | 1.510 |
Why?
| | Spinal Cord Injuries | 7 | 2021 | 173 | 1.500 |
Why?
| | Walking Speed | 4 | 2022 | 35 | 1.470 |
Why?
| | Muscular Atrophy | 10 | 2022 | 74 | 1.450 |
Why?
| | Physical Therapists | 4 | 2020 | 38 | 1.450 |
Why?
| | Edema | 4 | 2022 | 119 | 1.440 |
Why?
| | Professional Role | 4 | 2019 | 153 | 1.320 |
Why?
| | Pain Measurement | 10 | 2021 | 449 | 1.280 |
Why?
| | Electric Impedance | 2 | 2019 | 99 | 1.280 |
Why?
| | Pyramidal Tracts | 2 | 2021 | 20 | 1.250 |
Why?
| | Frailty | 3 | 2022 | 116 | 1.240 |
Why?
| | Exercise | 14 | 2022 | 1609 | 1.200 |
Why?
| | Biofeedback, Psychology | 2 | 2020 | 25 | 1.200 |
Why?
| | Postoperative Complications | 9 | 2019 | 2161 | 1.160 |
Why?
| | Transitional Care | 2 | 2019 | 37 | 1.150 |
Why?
| | Walk Test | 6 | 2021 | 53 | 1.140 |
Why?
| | Dementia | 2 | 2020 | 185 | 1.110 |
Why?
| | Joint Diseases | 2 | 2017 | 59 | 1.110 |
Why?
| | Movement | 5 | 2020 | 246 | 1.070 |
Why?
| | Electric Stimulation Therapy | 6 | 2022 | 56 | 1.050 |
Why?
| | Torque | 9 | 2017 | 65 | 1.040 |
Why?
| | Weight-Bearing | 7 | 2017 | 165 | 1.020 |
Why?
| | Treatment Outcome | 23 | 2022 | 9159 | 1.010 |
Why?
| | Postoperative Period | 9 | 2021 | 292 | 1.010 |
Why?
| | Immobilization | 5 | 2010 | 44 | 1.000 |
Why?
| | Fee-for-Service Plans | 3 | 2020 | 79 | 0.990 |
Why?
| | Electric Stimulation | 7 | 2022 | 263 | 0.990 |
Why?
| | Aftercare | 3 | 2022 | 187 | 0.940 |
Why?
| | Rehabilitation | 2 | 2021 | 13 | 0.920 |
Why?
| | Prospective Studies | 21 | 2022 | 6264 | 0.910 |
Why?
| | Geriatric Assessment | 3 | 2020 | 176 | 0.910 |
Why?
| | Muscle Contraction | 12 | 2022 | 397 | 0.870 |
Why?
| | Frail Elderly | 3 | 2020 | 105 | 0.860 |
Why?
| | Amputees | 3 | 2018 | 62 | 0.830 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2020 | 1216 | 0.790 |
Why?
| | Self Report | 5 | 2021 | 698 | 0.770 |
Why?
| | Leg | 7 | 2016 | 227 | 0.760 |
Why?
| | Health Services for the Aged | 2 | 2019 | 70 | 0.750 |
Why?
| | Veterans | 5 | 2020 | 1233 | 0.750 |
Why?
| | Cross-Sectional Studies | 16 | 2021 | 4435 | 0.750 |
Why?
| | Retrospective Studies | 18 | 2022 | 12608 | 0.750 |
Why?
| | Comorbidity | 4 | 2020 | 1473 | 0.740 |
Why?
| | Systems Analysis | 1 | 2020 | 22 | 0.740 |
Why?
| | Single-Blind Method | 6 | 2020 | 255 | 0.720 |
Why?
| | Pain | 7 | 2021 | 712 | 0.700 |
Why?
| | Health Care Reform | 1 | 2021 | 92 | 0.700 |
Why?
| | Hip Joint | 4 | 2019 | 131 | 0.700 |
Why?
| | Hip Fractures | 1 | 2021 | 75 | 0.700 |
Why?
| | Longitudinal Studies | 9 | 2022 | 2416 | 0.690 |
Why?
| | Arthroplasty, Replacement | 1 | 2020 | 45 | 0.670 |
Why?
| | Muscle Strength Dynamometer | 6 | 2020 | 21 | 0.650 |
Why?
| | Thigh | 5 | 2012 | 53 | 0.640 |
Why?
| | Muscle Fibers, Skeletal | 5 | 2022 | 169 | 0.640 |
Why?
| | Case-Control Studies | 13 | 2015 | 3022 | 0.640 |
Why?
| | Pain, Postoperative | 2 | 2019 | 195 | 0.630 |
Why?
| | Fatigue | 3 | 2019 | 296 | 0.600 |
Why?
| | Testosterone | 1 | 2021 | 337 | 0.590 |
Why?
| | Patient Transfer | 1 | 2019 | 143 | 0.590 |
Why?
| | High-Intensity Interval Training | 1 | 2017 | 18 | 0.590 |
Why?
| | Bone Malalignment | 1 | 2017 | 14 | 0.580 |
Why?
| | Accelerometry | 3 | 2019 | 72 | 0.560 |
Why?
| | Delivery of Health Care | 2 | 2021 | 844 | 0.560 |
Why?
| | Quality Improvement | 3 | 2021 | 958 | 0.550 |
Why?
| | Health Behavior | 3 | 2019 | 707 | 0.530 |
Why?
| | Self-Management | 1 | 2018 | 126 | 0.530 |
Why?
| | Behavior Therapy | 1 | 2018 | 224 | 0.530 |
Why?
| | Ankle Injuries | 3 | 2006 | 74 | 0.520 |
Why?
| | Knee Prosthesis | 1 | 2015 | 15 | 0.520 |
Why?
| | Homebound Persons | 1 | 2015 | 4 | 0.520 |
Why?
| | Tourniquets | 1 | 2016 | 28 | 0.520 |
Why?
| | Telemedicine | 3 | 2022 | 667 | 0.510 |
Why?
| | United States | 13 | 2022 | 12295 | 0.510 |
Why?
| | Telerehabilitation | 3 | 2022 | 26 | 0.500 |
Why?
| | Patient Care Planning | 1 | 2016 | 142 | 0.500 |
Why?
| | Biomechanical Phenomena | 6 | 2018 | 677 | 0.500 |
Why?
| | Physical Conditioning, Human | 1 | 2015 | 24 | 0.500 |
Why?
| | Phenotype | 3 | 2021 | 2829 | 0.480 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2012 | 154 | 0.480 |
Why?
| | Evoked Potentials, Motor | 1 | 2014 | 35 | 0.480 |
Why?
| | Peripheral Vascular Diseases | 1 | 2015 | 98 | 0.470 |
Why?
| | Motor Cortex | 1 | 2014 | 47 | 0.470 |
Why?
| | Electromyography | 6 | 2014 | 324 | 0.470 |
Why?
| | Community Health Services | 1 | 2016 | 212 | 0.460 |
Why?
| | Models, Biological | 3 | 2021 | 1646 | 0.460 |
Why?
| | Artificial Limbs | 2 | 2018 | 116 | 0.460 |
Why?
| | Physical Endurance | 1 | 2015 | 223 | 0.460 |
Why?
| | Musculoskeletal Pain | 1 | 2013 | 23 | 0.450 |
Why?
| | Tendons | 1 | 2014 | 120 | 0.440 |
Why?
| | Time Factors | 10 | 2021 | 6165 | 0.440 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 123 | 0.440 |
Why?
| | Arthralgia | 1 | 2013 | 50 | 0.430 |
Why?
| | Restless Legs Syndrome | 1 | 2012 | 18 | 0.430 |
Why?
| | Public Health | 1 | 2017 | 438 | 0.410 |
Why?
| | Risk Factors | 9 | 2021 | 8697 | 0.390 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2010 | 281 | 0.380 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 906 | 0.380 |
Why?
| | Time-to-Treatment | 1 | 2012 | 147 | 0.370 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2010 | 8 | 0.370 |
Why?
| | Fractures, Bone | 2 | 2006 | 372 | 0.360 |
Why?
| | Occupational Therapy | 2 | 2022 | 73 | 0.350 |
Why?
| | Cohort Studies | 6 | 2020 | 4944 | 0.340 |
Why?
| | Mobile Applications | 2 | 2022 | 140 | 0.330 |
Why?
| | Linear Models | 4 | 2019 | 776 | 0.320 |
Why?
| | Guillain-Barre Syndrome | 1 | 2008 | 21 | 0.320 |
Why?
| | Patient Participation | 3 | 2021 | 363 | 0.320 |
Why?
| | Colorado | 5 | 2019 | 4113 | 0.320 |
Why?
| | Nursing Homes | 2 | 2020 | 136 | 0.320 |
Why?
| | Quality of Life | 6 | 2022 | 2385 | 0.320 |
Why?
| | Magnetic Resonance Imaging | 6 | 2021 | 3069 | 0.310 |
Why?
| | Follow-Up Studies | 6 | 2019 | 4440 | 0.310 |
Why?
| | Age Factors | 5 | 2020 | 2907 | 0.300 |
Why?
| | Adult | 20 | 2021 | 30718 | 0.290 |
Why?
| | Qualitative Research | 3 | 2021 | 971 | 0.290 |
Why?
| | Reproducibility of Results | 4 | 2020 | 2800 | 0.290 |
Why?
| | Cancer Survivors | 2 | 2021 | 203 | 0.290 |
Why?
| | Disabled Persons | 2 | 2019 | 135 | 0.290 |
Why?
| | Pilot Projects | 4 | 2022 | 1377 | 0.280 |
Why?
| | Absorptiometry, Photon | 2 | 2021 | 221 | 0.270 |
Why?
| | Muscle Fatigue | 3 | 2003 | 86 | 0.270 |
Why?
| | Running | 1 | 2008 | 209 | 0.270 |
Why?
| | Motor Activity | 4 | 2016 | 633 | 0.260 |
Why?
| | Predictive Value of Tests | 4 | 2021 | 1805 | 0.250 |
Why?
| | Self Care | 2 | 2020 | 354 | 0.250 |
Why?
| | Analysis of Variance | 3 | 2019 | 1227 | 0.250 |
Why?
| | Tibia | 2 | 2018 | 172 | 0.250 |
Why?
| | Lipid Metabolism | 1 | 2008 | 449 | 0.250 |
Why?
| | Patient Satisfaction | 3 | 2020 | 585 | 0.240 |
Why?
| | Regression Analysis | 4 | 2012 | 959 | 0.240 |
Why?
| | Adipose Tissue | 1 | 2008 | 555 | 0.230 |
Why?
| | Blood Loss, Surgical | 2 | 2016 | 86 | 0.230 |
Why?
| | Aging | 2 | 2003 | 1631 | 0.210 |
Why?
| | Clinical Trials as Topic | 2 | 2018 | 941 | 0.210 |
Why?
| | Preoperative Care | 4 | 2020 | 318 | 0.210 |
Why?
| | Preoperative Period | 2 | 2014 | 103 | 0.200 |
Why?
| | Body Mass Index | 1 | 2009 | 1971 | 0.200 |
Why?
| | Muscular Diseases | 1 | 2003 | 104 | 0.200 |
Why?
| | Transcutaneous Electric Nerve Stimulation | 1 | 2001 | 17 | 0.190 |
Why?
| | Phosphates | 3 | 2008 | 160 | 0.190 |
Why?
| | Torso | 1 | 2021 | 30 | 0.190 |
Why?
| | Patient Compliance | 3 | 2020 | 524 | 0.190 |
Why?
| | Leisure Activities | 1 | 2021 | 24 | 0.190 |
Why?
| | Administration, Topical | 1 | 2021 | 137 | 0.180 |
Why?
| | Communicable Disease Control | 1 | 2021 | 66 | 0.180 |
Why?
| | Radiography | 2 | 2013 | 826 | 0.180 |
Why?
| | Anesthetics, Local | 2 | 2012 | 84 | 0.180 |
Why?
| | Mentoring | 1 | 2022 | 101 | 0.180 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 250 | 0.180 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 21 | 0.180 |
Why?
| | Delphi Technique | 1 | 2020 | 164 | 0.170 |
Why?
| | Cardiovascular Deconditioning | 1 | 2019 | 4 | 0.170 |
Why?
| | Insurance Claim Review | 1 | 2020 | 67 | 0.170 |
Why?
| | Stakeholder Participation | 1 | 2020 | 73 | 0.170 |
Why?
| | Cardiac Rehabilitation | 1 | 2020 | 33 | 0.170 |
Why?
| | Dependent Ambulation | 2 | 2019 | 9 | 0.170 |
Why?
| | Nociception | 1 | 2019 | 17 | 0.170 |
Why?
| | Androgens | 1 | 2021 | 165 | 0.170 |
Why?
| | Dimensional Measurement Accuracy | 1 | 2019 | 12 | 0.170 |
Why?
| | Patient-Specific Modeling | 1 | 2019 | 37 | 0.160 |
Why?
| | Focus Groups | 1 | 2021 | 393 | 0.160 |
Why?
| | Delaware | 1 | 2018 | 3 | 0.160 |
Why?
| | Research Design | 3 | 2020 | 946 | 0.160 |
Why?
| | Independent Living | 1 | 2020 | 84 | 0.160 |
Why?
| | Postoperative Care | 1 | 2020 | 222 | 0.160 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2578 | 0.160 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 815 | 0.160 |
Why?
| | Rehabilitation Research | 1 | 2018 | 6 | 0.160 |
Why?
| | Hindlimb | 2 | 2010 | 125 | 0.160 |
Why?
| | Drainage | 1 | 2019 | 151 | 0.160 |
Why?
| | Bayes Theorem | 1 | 2020 | 334 | 0.160 |
Why?
| | Lung Neoplasms | 2 | 2021 | 2207 | 0.160 |
Why?
| | Ambulatory Care | 2 | 2019 | 478 | 0.160 |
Why?
| | Feasibility Studies | 4 | 2022 | 741 | 0.150 |
Why?
| | Consensus | 1 | 2020 | 532 | 0.150 |
Why?
| | Physical Fitness | 2 | 2013 | 179 | 0.150 |
Why?
| | Physical and Rehabilitation Medicine | 1 | 2018 | 28 | 0.150 |
Why?
| | Patient Admission | 1 | 2019 | 175 | 0.150 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 249 | 0.150 |
Why?
| | Hamstring Muscles | 1 | 2017 | 13 | 0.150 |
Why?
| | Bone Density | 1 | 2021 | 432 | 0.140 |
Why?
| | Monitoring, Physiologic | 1 | 2019 | 250 | 0.140 |
Why?
| | Guidelines as Topic | 1 | 2018 | 248 | 0.140 |
Why?
| | Neuromuscular Diseases | 1 | 2017 | 90 | 0.140 |
Why?
| | Health Services Research | 1 | 2019 | 377 | 0.140 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 390 | 0.130 |
Why?
| | Patient Discharge Summaries | 1 | 2016 | 10 | 0.130 |
Why?
| | Risk | 1 | 2019 | 819 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2022 | 2098 | 0.130 |
Why?
| | Likelihood Functions | 1 | 2016 | 128 | 0.130 |
Why?
| | Proportional Hazards Models | 1 | 2019 | 1087 | 0.130 |
Why?
| | Outpatients | 1 | 2019 | 330 | 0.130 |
Why?
| | Osteoarthritis | 1 | 2018 | 173 | 0.130 |
Why?
| | Operative Time | 1 | 2016 | 109 | 0.130 |
Why?
| | Double-Blind Method | 1 | 2019 | 1660 | 0.130 |
Why?
| | Volition | 3 | 2008 | 29 | 0.130 |
Why?
| | Acceleration | 1 | 2015 | 30 | 0.130 |
Why?
| | ROC Curve | 2 | 2013 | 451 | 0.130 |
Why?
| | Forecasting | 2 | 2018 | 333 | 0.120 |
Why?
| | Pneumonia | 1 | 2020 | 576 | 0.120 |
Why?
| | Statistics as Topic | 1 | 2016 | 299 | 0.120 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 1 | 2016 | 116 | 0.120 |
Why?
| | Appetite | 1 | 2015 | 53 | 0.120 |
Why?
| | Sex Factors | 2 | 2020 | 1736 | 0.120 |
Why?
| | Femoral Nerve | 2 | 2012 | 15 | 0.120 |
Why?
| | Critical Illness | 1 | 2020 | 645 | 0.120 |
Why?
| | Patient-Centered Care | 1 | 2020 | 477 | 0.120 |
Why?
| | Arthrometry, Articular | 1 | 2014 | 9 | 0.120 |
Why?
| | Fibrosis | 1 | 2017 | 457 | 0.120 |
Why?
| | Self Efficacy | 1 | 2018 | 361 | 0.120 |
Why?
| | Postural Balance | 2 | 2015 | 182 | 0.120 |
Why?
| | Syndrome | 1 | 2015 | 339 | 0.120 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2014 | 43 | 0.120 |
Why?
| | Documentation | 1 | 2016 | 169 | 0.120 |
Why?
| | Nerve Block | 2 | 2012 | 62 | 0.120 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 2 | 2010 | 24 | 0.110 |
Why?
| | Combined Modality Therapy | 2 | 2009 | 1127 | 0.110 |
Why?
| | Receptor, IGF Type 1 | 2 | 2010 | 58 | 0.110 |
Why?
| | Logistic Models | 2 | 2021 | 1856 | 0.110 |
Why?
| | Prognosis | 3 | 2020 | 3339 | 0.110 |
Why?
| | Neural Inhibition | 1 | 2014 | 152 | 0.110 |
Why?
| | Ankle Joint | 3 | 2019 | 155 | 0.110 |
Why?
| | Traction | 1 | 2012 | 15 | 0.110 |
Why?
| | Risk Assessment | 2 | 2020 | 2987 | 0.110 |
Why?
| | Area Under Curve | 1 | 2013 | 278 | 0.110 |
Why?
| | Digestive System Surgical Procedures | 1 | 2013 | 89 | 0.110 |
Why?
| | Algorithms | 3 | 2017 | 1490 | 0.100 |
Why?
| | Physical Examination | 1 | 2014 | 222 | 0.100 |
Why?
| | Elective Surgical Procedures | 1 | 2013 | 154 | 0.100 |
Why?
| | Decision Trees | 1 | 2012 | 81 | 0.100 |
Why?
| | Repressor Proteins | 1 | 1995 | 369 | 0.100 |
Why?
| | Cardiovascular Diseases | 2 | 2020 | 1724 | 0.100 |
Why?
| | Anthropometry | 1 | 2012 | 181 | 0.100 |
Why?
| | Hospitals | 1 | 2016 | 585 | 0.100 |
Why?
| | Patient Education as Topic | 1 | 2016 | 686 | 0.090 |
Why?
| | Escherichia coli | 1 | 1995 | 730 | 0.090 |
Why?
| | Treatment Failure | 1 | 2012 | 332 | 0.090 |
Why?
| | Depression | 1 | 2019 | 1145 | 0.090 |
Why?
| | Protons | 2 | 2008 | 80 | 0.090 |
Why?
| | Torsion, Mechanical | 1 | 2010 | 7 | 0.090 |
Why?
| | Communication | 1 | 2016 | 750 | 0.090 |
Why?
| | Dependovirus | 1 | 2010 | 51 | 0.090 |
Why?
| | Myogenic Regulatory Factors | 1 | 2010 | 47 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2013 | 353 | 0.090 |
Why?
| | Anesthesia, Conduction | 1 | 2010 | 22 | 0.090 |
Why?
| | Models, Theoretical | 1 | 2013 | 519 | 0.090 |
Why?
| | Random Allocation | 1 | 2010 | 337 | 0.090 |
Why?
| | Chronic Disease | 1 | 2015 | 1598 | 0.080 |
Why?
| | Gene Transfer Techniques | 1 | 2010 | 148 | 0.080 |
Why?
| | Bacterial Proteins | 1 | 1995 | 739 | 0.080 |
Why?
| | Cardiac Surgical Procedures | 1 | 2013 | 413 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2008 | 482 | 0.080 |
Why?
| | Transcription, Genetic | 1 | 1995 | 1310 | 0.080 |
Why?
| | Hypertrophy | 2 | 2010 | 110 | 0.080 |
Why?
| | Confidence Intervals | 2 | 2021 | 309 | 0.080 |
Why?
| | Oxidative Stress | 1 | 1995 | 1093 | 0.080 |
Why?
| | Muscle Proteins | 1 | 2010 | 209 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 930 | 0.080 |
Why?
| | Hindlimb Suspension | 1 | 2008 | 20 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 1995 | 1316 | 0.080 |
Why?
| | Physical Conditioning, Animal | 1 | 2010 | 191 | 0.080 |
Why?
| | Health Surveys | 1 | 2009 | 446 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 4665 | 0.070 |
Why?
| | Paralysis | 1 | 2008 | 67 | 0.070 |
Why?
| | Transcription Factors | 1 | 1995 | 1528 | 0.070 |
Why?
| | Body Composition | 2 | 2008 | 580 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1642 | 0.070 |
Why?
| | Mental Health | 2 | 2022 | 571 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2013 | 974 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2010 | 2262 | 0.060 |
Why?
| | Patient Safety | 2 | 2019 | 276 | 0.060 |
Why?
| | RNA | 1 | 2010 | 819 | 0.060 |
Why?
| | Rats | 2 | 2010 | 5034 | 0.050 |
Why?
| | Preliminary Data | 1 | 2022 | 8 | 0.050 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2021 | 44 | 0.050 |
Why?
| | Imaging, Three-Dimensional | 1 | 2004 | 495 | 0.050 |
Why?
| | Mice, Inbred C57BL | 1 | 2010 | 4773 | 0.050 |
Why?
| | Adaptation, Physiological | 1 | 2004 | 476 | 0.050 |
Why?
| | Motion Therapy, Continuous Passive | 1 | 2020 | 1 | 0.050 |
Why?
| | Cryotherapy | 1 | 2020 | 16 | 0.050 |
Why?
| | Animals | 4 | 2010 | 32102 | 0.050 |
Why?
| | Peer Review | 1 | 2020 | 43 | 0.040 |
Why?
| | Multiple Sclerosis | 1 | 2004 | 380 | 0.040 |
Why?
| | Myalgia | 1 | 2019 | 14 | 0.040 |
Why?
| | Pain Threshold | 1 | 2019 | 67 | 0.040 |
Why?
| | Survivors | 1 | 2022 | 404 | 0.040 |
Why?
| | Knee | 1 | 2019 | 50 | 0.040 |
Why?
| | Confidentiality | 1 | 2019 | 67 | 0.040 |
Why?
| | Wearable Electronic Devices | 1 | 2019 | 34 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 380 | 0.040 |
Why?
| | Informed Consent | 1 | 2019 | 161 | 0.040 |
Why?
| | Expert Testimony | 1 | 2018 | 55 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 107 | 0.040 |
Why?
| | Reaction Time | 1 | 2019 | 373 | 0.040 |
Why?
| | Hip | 1 | 2018 | 46 | 0.040 |
Why?
| | Self-Assessment | 1 | 2018 | 63 | 0.040 |
Why?
| | Femur Head | 1 | 2018 | 35 | 0.040 |
Why?
| | Hip Prosthesis | 1 | 2018 | 33 | 0.040 |
Why?
| | Obesity | 1 | 2009 | 2517 | 0.040 |
Why?
| | Psychometrics | 1 | 2020 | 615 | 0.040 |
Why?
| | Feedback | 1 | 2017 | 148 | 0.040 |
Why?
| | Diabetic Angiopathies | 1 | 2019 | 244 | 0.040 |
Why?
| | Mice | 2 | 2010 | 15052 | 0.040 |
Why?
| | Congresses as Topic | 1 | 2018 | 204 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2021 | 1086 | 0.040 |
Why?
| | Health Status | 1 | 2021 | 728 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2020 | 622 | 0.030 |
Why?
| | Amputation, Traumatic | 1 | 2016 | 22 | 0.030 |
Why?
| | Perception | 1 | 2018 | 315 | 0.030 |
Why?
| | Casts, Surgical | 2 | 2006 | 31 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 234 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2017 | 434 | 0.030 |
Why?
| | Decision Making | 1 | 2021 | 791 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1995 | 352 | 0.030 |
Why?
| | Myosin Heavy Chains | 1 | 2015 | 169 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 1995 | 372 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 1995 | 511 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 1995 | 309 | 0.030 |
Why?
| | Escherichia coli Proteins | 1 | 1995 | 164 | 0.030 |
Why?
| | Peripheral Arterial Disease | 1 | 2019 | 379 | 0.030 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 1995 | 284 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 1995 | 616 | 0.030 |
Why?
| | Protein Conformation | 1 | 1995 | 822 | 0.020 |
Why?
| | Biopsy | 1 | 2015 | 1056 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 1995 | 924 | 0.020 |
Why?
| | Base Sequence | 1 | 1995 | 2114 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1995 | 2000 | 0.020 |
Why?
| | Anesthesia, Spinal | 1 | 2010 | 4 | 0.020 |
Why?
| | Anesthesia Recovery Period | 1 | 2010 | 9 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1995 | 2790 | 0.020 |
Why?
| | Paired Box Transcription Factors | 1 | 2010 | 37 | 0.020 |
Why?
| | Endpoint Determination | 1 | 2010 | 69 | 0.020 |
Why?
| | Muscle Development | 1 | 2010 | 93 | 0.020 |
Why?
| | Protein Binding | 1 | 1995 | 1917 | 0.020 |
Why?
| | Amides | 1 | 2010 | 88 | 0.020 |
Why?
| | Lung | 1 | 2021 | 3672 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2010 | 374 | 0.020 |
Why?
| | Regeneration | 1 | 2010 | 162 | 0.020 |
Why?
| | Phosphocreatine | 1 | 2008 | 36 | 0.020 |
Why?
| | Rest | 1 | 2008 | 100 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2008 | 399 | 0.020 |
Why?
| | Mitochondria, Muscle | 1 | 2008 | 92 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2008 | 431 | 0.020 |
Why?
| | Teaching | 1 | 2008 | 224 | 0.020 |
Why?
| | Inorganic Chemicals | 1 | 2004 | 2 | 0.020 |
Why?
| | Ischemia | 1 | 2008 | 363 | 0.020 |
Why?
| | Adolescent | 1 | 2003 | 17889 | 0.020 |
Why?
| | Nutrition Assessment | 1 | 2004 | 75 | 0.010 |
Why?
| | Phosphorylation | 1 | 2008 | 1571 | 0.010 |
Why?
| | Stress, Mechanical | 1 | 2004 | 440 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2010 | 2574 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2010 | 3580 | 0.010 |
Why?
|
|
Stevens Lapsley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|